Maravai MRVI Q1 2026 Earnings Why the Beat Matters Standard SMP Stock Up 280 Key Resistance at 3898 20260520 Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Potential Market Recovery in Coming Quarters IDEAYA Biosciences IDYA Q1 2026 Disappoints EPS 111 Below 101 Views Spyre Therapeutics SYRE Stock Analysis Climbs 796 Eyes on 7552 20260520 FutureCrest FCRS at 1026 Buy Sell or Hold 20260520